Daiwa Securities Group Inc. Grows Position in Henry Schein, Inc. (NASDAQ:HSIC)

Daiwa Securities Group Inc. raised its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 9.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,040 shares of the company’s stock after buying an additional 1,171 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Henry Schein were worth $900,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in HSIC. Swedbank AB purchased a new position in Henry Schein during the first quarter valued at $215,998,000. Norges Bank purchased a new position in Henry Schein during the fourth quarter valued at $111,715,000. Nuance Investments LLC raised its stake in Henry Schein by 28.5% during the first quarter. Nuance Investments LLC now owns 1,755,190 shares of the company’s stock valued at $132,552,000 after buying an additional 388,843 shares during the last quarter. Fiduciary Management Inc. WI raised its stake in Henry Schein by 17.1% during the fourth quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock valued at $172,947,000 after buying an additional 333,855 shares during the last quarter. Finally, KBC Group NV raised its stake in Henry Schein by 163.5% during the fourth quarter. KBC Group NV now owns 521,964 shares of the company’s stock valued at $39,518,000 after buying an additional 323,901 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Activity at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.14% of the stock is owned by company insiders.

Analysts Set New Price Targets

HSIC has been the subject of a number of recent research reports. Robert W. Baird lowered their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Evercore ISI reduced their target price on Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a report on Wednesday, August 7th. JPMorgan Chase & Co. reduced their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. Barrington Research reduced their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Finally, UBS Group cut their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Henry Schein has a consensus rating of “Hold” and an average target price of $77.10.

Henry Schein Price Performance

NASDAQ HSIC opened at $70.38 on Monday. The company has a market capitalization of $8.92 billion, a PE ratio of 23.78, a price-to-earnings-growth ratio of 1.88 and a beta of 0.86. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. The business’s fifty day moving average is $69.21 and its 200 day moving average is $70.52. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $82.63.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.01. The company had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. Henry Schein’s quarterly revenue was up .0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.31 earnings per share. Sell-side analysts predict that Henry Schein, Inc. will post 4.75 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.